-+ 0.00%
-+ 0.00%
-+ 0.00%

LIMINATUS PHARMA ANNOUNCES TRANSFER TO NASDAQ CAPITAL MARKET AND EXTENSION TO REGAIN COMPLIANCE WITH MINIMUM BID PRICE REQUIREMENT

Reuters·08/13/2026 11:15:35

Please log in to view news